MARATTO

article · Biomarkers

Dielectric ionic conductivity as a biomarker for lead chelation using nano-ZnO/CMC in albino rats

Abstract

BACKGROUND: This study evaluates dielectric conductivity as a diagnostic tool for assessing lead (Pb) levels in albino rats. It also investigated the ameliorative potentials of nano-ZnO-capped sodium carboxymethyl cellulose (nZnO/CMC). METHODS: The synthesis of nZnO/CMC was carried out using the co-precipitation technique. The average crystallite size obtained from X-ray diffraction measurements is 33 nm. The effect of Pb induced toxicity was evaluated using four groups of six albino rats each, administered with Pb for 61 days. Haematological results show decreasing trends in packed cell volume, red blood and white blood cell counts, and haemoglobin concentration with Pb administration, indicating anaemia. RESULTS: . Dielectric conductivity of normal and exposed blood samples measured between 200 Hz and 4 MHz shows dominance of ionic conductivity; highest for Pb-exposed samples and lowest for the normal/control sample. It also showed a decreasing trend for samples treated with nZnO/CMC at 100 and 200 mg/kg. CONCLUSIONS: This work strongly correlates changes in dielectric ionic conductivity with haematological/Pb exposure concentration, suggesting that dielectric ionic conductivity of blood is a promising biomarker for Pb-exposed animals.

Research topics

  • Microfluidic and Bio-sensing Technologies
  • Electrical and Bioimpedance Tomography
  • Heavy Metal Exposure and Toxicity

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/1354750x.2026.2620721

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.